The history of the erectile dysfunction drug presents a intricate picture for investors. While the initial introduction generated substantial returns, the end of its exclusive rights opened the door to cheaper https://bookmarkinglive.com/story22713887/sildenafil-and-big-pharma-a-volatile-opportunity